Eris Lifesciences acquires trademark Zomelis (for Vildagliptin) from Novartis AG for India market
Zomelis is used in the treatment of type 2 diabetes and comes under a new class of anti-diabetic drugs known as DPP 4 inhibitors
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.